Clinical trial
A Randomized, Dose Ranging Trial of Mesalmine for the Treatment of Active Microscopic Colitis.
NCT00952952 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Dose Ranging Trial of Mesalmine for the Treatment of Active Microscopic Colitis.
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- November 30, 2007
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diarrhea, microscopic colitis